Independent serum metabolomics approaches identify disrupted glutamic acid and serine metabolism in Parkinson’s disease patients

Whether distinct blood metabolomic profiles can distinguish Parkinson's disease (PD) patients from healthy controls (HC) is still a matter of debate. Here, we employed ¹H-NMR and UPLC/MS analyses on serum samples from a cohort of PD patients and HC. Compared to HC, PD patients showed: (1) higher glutamine, serine, pyruvate and lower α-ketoglutarate levels (<sup>1</sup>H-NMR); (2) higher glycine and lower glutamic acid concentrations (UPLC/MS). Several pathways associated with amino acids, mitochondrial and antioxidant metabolism emerged as dysregulated in PD. Our findings highlight a prominent disruption of cellular bioenergetic pathways and amino acid homeostasis in PD.

Authors

Institutions

Publication Details

Journal
npj Parkinson s Disease
Published
2025-09-25
DOI
https://doi.org/10.1038/s41531-025-01126-5
Citations
7
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
9.72

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Independent serum metabolomics approaches identify disrupted glutamic acid and serine metabolism in Parkinson’s disease patients

Alessandro Usiello, Anna Maria D’Ursi, Claudio Pacchetti, Caterina Galandra et al.
7 citations
npj Parkinson s Disease
Parkinson's Disease Mechanisms and Treatments
9.72
article

Independent serum metabolomics approaches identify disrupted glutamic acid and serine metabolism in Parkinson’s disease patients

Alessandro Usiello, Anna Maria D’Ursi, Claudio Pacchetti, Caterina Galandra, Lavinia Santucci, Manuela Grimaldi, Marta Picascia, Gabriele Buongarzone, Francesco Errico, Tommaso Nuzzo, Enza Maria Valente, Alberto Imarisio, Andrea Urbani, Jacopo Gervasoni, Enza Napolitano, Micol Avenali, Isar Yahyavi, Michela Cicchinelli, Carmen Marino
article en
7 citations

Abstract

Whether distinct blood metabolomic profiles can distinguish Parkinson's disease (PD) patients from healthy controls (HC) is still a matter of debate. Here, we employed ¹H-NMR and UPLC/MS analyses on serum samples from a cohort of PD patients and HC. Compared to HC, PD patients showed: (1) higher glutamine, serine, pyruvate and lower α-ketoglutarate levels (<sup>1</sup>H-NMR); (2) higher glycine and lower glutamic acid concentrations (UPLC/MS). Several pathways associated with amino acids, mitochondrial and antioxidant metabolism emerged as dysregulated in PD. Our findings highlight a prominent disruption of cellular bioenergetic pathways and amino acid homeostasis in PD.

npj Parkinson s DiseaseVol. 11(1)
Università Cattolica del Sacro Cuore (IT), University of Salerno (IT), University of Campania "Luigi Vanvitelli" (IT), University of Pavia (IT), Agostino Gemelli University Polyclinic (IT), Foundation Center (US), Fondazione Istituto Neurologico Nazionale Casimiro Mondino (IT), Urology Foundation (GB), Federico II University Hospital (IT), University of Campania "Luigi Vanvitelli" (IT), CEINGE Biotecnologie Avanzate Franco Salvatore (Italy) (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), University of Naples Federico II (IT)
Clinical Trial Center, China Medical University Hospital, Fondazione Cariplo, Ministero della Salute
Openalex Percentile: Top 2%
Parkinson's Disease Mechanisms and Treatments
9.72
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.